Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6.

scientific article published on 19 August 2014

Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1006090516
P356DOI10.1038/BJC.2014.457
P932PMC publication ID4200097
P698PubMed publication ID25137020
P5875ResearchGate publication ID264866477

P50authorNorman MaitlandQ37392064
P2093author name stringA Noble
M Otsuka
J Schmitt
M G Rumsby
P Berry
P2860cites workMeasurement of Phospholipase D ActivityQ56029518
Abnormal Choline Phospholipid Metabolism in Breast and Ovary Cancer:Molecular Bases for Noninvasive Imaging ApproachesQ57738618
Importance of phosphatidylethanolamine for association of protein kinase C and other cytoplasmic proteins with membranesQ67741637
Effect of ethanolamine on choline uptake and incorporation into phosphatidylcholine in human Y79 retinoblastoma cellsQ68965266
Involvement of phosphatidylcholine-specific phospholipase C in platelet-derived growth factor-induced activation of the mitogen-activated protein kinase pathway in Rat-1 fibroblastsQ73248197
Cellular mechanism of sodium oleate-stimulated secretion of cholecystokinin and secretinQ74070922
Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostateQ75247553
Fatty acid composition of phospholipids in epithelium and stroma of human benign prostatic hyperplasiaQ77155915
Metabolic changes underlying 31P MR spectral alterations in human hepatic tumoursQ77707836
Epithelial cell motility is triggered by activation of the EGF receptor through phosphatidic acid signalingQ82995091
Ethanolamine modulates DNA synthesis through epidermal growth factor receptor in rat primary hepatocytesQ83161094
Phospholipase D in cell proliferation and cancerQ28205631
Phosphorylation-dependent regulation of phospholipase D2 by protein kinase C delta in rat Pheochromocytoma PC12 cellsQ28211330
Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancersQ28217662
Hepatic phosphatidylethanolamine N-methyltransferase, unexpected roles in animal biochemistry and physiologyQ28249732
Phospholipase DQ28253553
Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipidsQ28265196
Phospholipase D: a lipid centric reviewQ28270831
Phosphocholine as a biomarker of breast cancer: molecular and biochemical studiesQ28284080
The methylation of phosphatidylethanolamineQ28289280
Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40Q28306173
Phospholipase D1b and D2a generate structurally identical phosphatidic acid species in mammalian cellsQ28365884
Parathyroid hormone stimulates phosphatidylethanolamine hydrolysis by phospholipase D in osteoblastic cellsQ28574700
Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancerQ30497364
Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis.Q30684622
Tumour phospholipid metabolismQ33179622
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cellsQ33699139
Phosphoethanolamine as a growth factor of a mammary carcinoma cell line of ratQ33980710
Facilitation of phospholipase A2 activity by mastoparans, a new class of mast cell degranulating peptides from wasp venomQ34056083
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.Q34066911
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell linesQ34095006
N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).Q34098506
Sphingosine 1-phosphate, a key cell signaling moleculeQ34128454
Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformaticsQ34477513
Properties of the Group IV phospholipase A2 familyQ34543677
Cytosolic phospholipase A2-α expression in breast cancer is associated with EGFR expression and correlates with an adverse prognosis in luminal tumours.Q34543740
Mitogenic action of LPA in prostateQ34691578
Lysophosphatidic acid as an autocrine and paracrine mediatorQ34691584
The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).Q35486098
Choline phospholipid metabolism: a target in cancer cells?Q35549481
Protein kinase C-alpha in prostate cancerQ35772647
The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor proteinQ35964273
Growth of hybridoma cells in serum-free medium: ethanolamine is an essential componentQ36282450
Signaling functions of phosphatidic acid.Q36436028
Phosphatidic acid- and phosphatidylserine-binding proteinsQ36453653
Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions.Q36607242
Ethanolamine modulates the rate of rat hepatocyte proliferation in vitro and in vivoQ36655187
Expression and function of fatty acid amide hydrolase in prostate cancer.Q36901770
Multi-targeted therapy of cancer by omega-3 fatty acidsQ36947010
Cytosolic phospholipase A2-alpha: a potential therapeutic target for prostate cancerQ37020802
Differential modulation of L-type calcium channel subunits by oleateQ37092809
Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy.Q37100440
Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycinQ37110578
Advances in MR spectroscopy of the prostateQ37300338
Molecular mechanisms of metastasis in prostate cancerQ37339692
Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cellsQ37380645
Occurrence, biosynthesis and functions of N-acylphosphatidylethanolamines (NAPE): not just precursors of N-acylethanolamines (NAE).Q37875929
A decade in prostate cancer: from NMR to metabolomicsQ37876681
Lipids and prostate cancerQ38002682
Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylationQ39054965
Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell linesQ39458740
Human prostate cell lines from normal and tumourigenic epithelia differ in the pattern and control of choline lipid headgroups released into the medium on stimulation of protein kinase C.Q39602697
Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cellsQ39836411
Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cellsQ39937512
D609, an inhibitor of phosphatidylcholine-specific phospholipase C, inhibits group IV cytosolic phospholipase A2.Q39952761
Comparison of radiolabeled choline and ethanolamine as probe for cancer detectionQ40009352
Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: implications in cancer therapy.Q40009485
CaV3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells.Q40019245
Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrestQ40214988
Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cellsQ40275073
Alterations of choline phospholipid metabolism in ovarian tumor progressionQ40360938
Effects of econazole on Ca2+ levels in and the growth of human prostate cancer PC3 cellsQ40371030
Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF.Q40456737
Inhibitors of protein kinase C.Q40507552
Endogenous phospholipase D2 localizes to the plasma membrane of RBL-2H3 mast cells and can be distinguished from ADP ribosylation factor-stimulated phospholipase D1 activity by its specific sensitivity to oleic acidQ40698369
Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cellsQ40809642
Expression and regulation of phospholipase D isoforms in mammalian cell linesQ40917037
Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cellsQ40979828
Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C?Q41035572
The protein kinase C inhibitors Ro 318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1beta (Rsk-2) and p70 S6 kinase.Q41128592
Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: a 31P- and 13C-nuclear magnetic resonance (NMR) spectroscopy studyQ41271051
Ethanolamine and choline transport in cultured bovine aortic endothelial cellsQ41404233
Binding of epidermal growth factor to its receptor is affected by membrane phospholipid environment.Q41711407
The ethanolamine requirement of keratinocytes for growth is not due to defective synthesis of ethanolamine phosphoacylglycerols by the decarboxylation pathwayQ41787701
G protein-independent stimulation of human myocardial phospholipase C by mastoparanQ41966245
Regulation of phospholipase D2 activity by protein kinase C alphaQ42458821
Phorbol ester-stimulated hydrolysis of phosphatidylcholine and phosphatidylethanolamine by phospholipase D in HeLa cells. Evidence that the basal turnover of phosphoglycerides does not involve phospholipase D.Q42473826
Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostatesQ42477282
Diacylglycerol and phosphatidate generated by phospholipases C and D, respectively, have distinct fatty acid compositions and functions. Phospholipase D-derived diacylglycerol does not activate protein kinase C in porcine aortic endothelial cellsQ42798711
Phorbol ester stimulates the hydrolysis of phosphatidylethanolamine in leukemic HL-60, NIH 3T3, and baby hamster kidney cellsQ42800167
Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysisQ42823337
Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties.Q42824955
Phorbol ester selectively stimulates the phospholipase D-mediated hydrolysis of phosphatidylethanolamine in multidrug-resistant MCF-7 human breast carcinoma cellsQ42829171
Ethanolamine, but not phosphoethanolamine, potentiates the effects of insulin, phosphocholine, and ATP on DNA synthesis in NIH 3T3 cells--role of mitogen-activated protein-kinase-dependent and protein-kinase-independent mechanismsQ42833186
Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancerQ42850126
Activation of betagamma subunits of G(i2) and G(i3) proteins by basic secretagogues induces exocytosis through phospholipase Cbeta and arachidonate release through phospholipase Cgamma in mast cells.Q43775036
Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumorsQ44161878
Anandamide and other N-acylethanolamines in human tumorsQ44233964
Mastoparan selectively activates phospholipase D2 in cell membranesQ44295705
Anti‐proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: Implication of epidermal growth factor receptor down‐regulation and ceramide productionQ44441030
31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasiaQ44673076
Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: inhibition of a phospholipase C-type reactionQ45185798
Cannabinoid receptor as a novel target for the treatment of prostate cancerQ45309097
Protein kinase C-{alpha} mediates epidermal growth factor receptor transactivation in human prostate cancer cellsQ46493494
Abnormal function of protein kinase C in cells having phosphatidylethanolamine-deficient and phosphatidylcholine-excess membranes.Q52223973
The recruitment of Raf-1 to membranes is mediated by direct interaction with phosphatidic acid and is independent of association with Ras.Q52539180
hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways.Q53581949
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectcancer cell lineQ23058136
P304page(s)1646-1656
P577publication date2014-08-19
P1433published inBritish Journal of CancerQ326309
P1476titlePhorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6.
P478volume111

Reverse relations

cites work (P2860)
Q92354803Bacterial Microcompartment-Mediated Ethanolamine Metabolism in Escherichia coli Urinary Tract Infection
Q39216218Diterpenes and Their Derivatives as Potential Anticancer Agents
Q55192374Evaluation of the bioactivity of a mastoparan peptide from wasp venom and of its analogues designed through targeted engineering.
Q47404758Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation
Q47243959SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis
Q36261136Synergistic Action of Genistein and Calcitriol in Immature Osteosarcoma MG-63 Cells by SGPL1 Up-Regulation.

Search more.